HUM
- Trade priority
- not ranked
- Data coverage
- 55%
- Setup
- no setup · 2026-10-02
- News
- negative
- Next catalyst
- Earnings in 24 sessions
Trade plan
No trade plan: the strategy has no valid setup for this symbol (trend or relative-strength condition fails (relative_strength_20)).
Your portfolio · San
- Profile
- Sanequity 2,000.00 USD · whole shares
- Current holding
- noneno open position in this profile
- Recommended quantity
- —no pending entry to size
- Risk budget
- 10.000.5% of 2,000.00
- Portfolio risk
- 0.00 opencap 2%
- Exposure
- 0 / 3 positionsHealthcare: 0 / 2 · 0.00 of 1,000.00 cap
- Cash impact
- 2,000.00derived from the ledger
- Eligibility
- AVOIDsame as the strategy view
Entry, stop, targets and R:R are strategy-owned and identical for every profile; only this portfolio's quantity, risk, exposure and cash differ. Manage profiles · record a fill
Why this action
Technical
- trend or relative-strength condition fails (relative_strength_20)
- RS20 vs SPY -4.0%, vs QQQ -8.9%
Options
- volume 0.91× the 20D baseline (neither) · selected contracts only, delayed
News and events
- news context negative (25 canonical items in window)
- high-materiality negative item on record
- earnings 2026-11-06 (24 sessions, finnhub); event risk high
- earnings · high · negative: Humana Reports Third-Quarter Earnings Nov. 6, in the Middle of Open Enrollment. Members Go
- other · low · unknown: UnitedHealth and Humana cutting Medicare Advantage plans in 2027
- insider · low · unknown: HUMANA INC: 4 filed
- other · low · positive: Humana Maintains Affordable Medicare Advantage Plans and Expands Specialized Care Options
Market and risk
- regime RISK ON: SPY: trend UP, volatility NORMAL; QQQ: trend UP, volatility NORMAL
Chart
Indicator history is derived from the stored bars with the accepted M3 functions (WORKSTATION_SERIES_V1); the scanner’s persisted values remain authoritative. Reconciliation at the scan session: 8 match.
Trade priority
Not ranked: only valid setups and gated setups enter the trade-priority ranking.
- technical readinessn/a
- structure quality10/10
- relative strength-1/15
- participation4/10
- risk rewardn/a
- news context0/10
- event risk5/5
- urgency3/5
operational attention priority not a return forecast. Missing inputs lower coverage, never the score.
Setup evidence · PRE_BREAKOUT_V1
- Setup state
- NO_SETUP
- Resistance
- 392.86
- Distance
- 1.15%
- Close
- 388.36
- SMA50
- 385.37
- SMA150 / SMA200
- 314.09 / 293.25
- RSI14
- 50.7
- EMA20 extension
- 0.09 ATR
- RS20 vs SPY
- -4.0%
- RS20 vs QQQ
- -8.9%
Hard requirements · 7/8 passed
- PASSConfirmed resistanceresistance=392.8589 exists eligible=true
- PASSDistance to resistancedistance_pct=1.1452 · resistance=392.8589 · close=388.36 inclusive_between min=0 · max=3
- PASSClose above SMA50close=388.36 · sma50=385.3658 > right_operand=sma50
- PASSSMA150 ≥ SMA200sma150=314.0923 · sma200=293.2488 >= right_operand=sma200
- PASSRSI14 bandrsi14=50.6532 inclusive_between min=50 · max=70
- PASSEMA20 extension (ATR)extension_atr=0.0909 · close=388.36 · ema20=387.1488 · atr14=13.318 <= max=1.5
- FAILRS20 vs SPY or QQQSPY=-0.0401 · QQQ=-0.0891 OR > SPY=0 · QQQ=0
- PASSResistance qualitydistinct_touches=3 policy_and_minimum_touches min=2
Supporting evidence · 2/6 passed
- PASSATR compressioncurrent_atr_pct=0.0343 · median_previous_60_atr_pct=0.0357 · ratio=0.9606 < right_operand=median_previous_60_atr_pct
- FAILVolume contractionrecent_volume=1,271,045.9932 · baseline_volume=970,039.6093 · ratio=1.3103 < max=0.85
- FAILHigher lowslow_1=382.11 · low_2=386.83 · low_3=369.1322 low_3 > low_2 > low_1 required_pivots=3
- PASSFull MA alignmentsma50=385.3658 · sma150=314.0923 · sma200=293.2488 sma50 > sma150 > sma200
- FAILRS20 vs SPY positiveSPY=-0.0401 > min=0
- FAILRS20 vs QQQ positiveQQQ=-0.0891 > min=0
PRE_BREAKOUT_V1 · scan run 413 · session 2026-10-02 · evaluated as of 2026-10-04T13:22:49.796150Z. Supporting evidence never changes the trigger; UNKNOWN is never collapsed into false.
Intelligence timeline
- 2026-10-0217:26 UTCCVS Health's Aetna and Centene are also shrinking their Medicare Advantage offerings as insurers pull back from less profitable markets
- 2026-10-0214:15 UTC
- 2026-10-0118:30 UTCHumana already told investors in July how many members it plans to drop. What your neighbor with a surviving plan has not figured out yet is how quietly the costs on that plan changed before open enrollment closes Dec. 7.
- 2026-10-0111:00 UTCLOUISVILLE, Ky., October 01, 2026--As Medicare’s Annual Election Period (AEP) begins Oct. 15, Humana is offering 2027 Medicare Advantage plans designed to deliver high-value coverage with affordable monthly premiums. Members will have continued access to the benefits they value most – including $0 cost-sharing on in-network primary care visits and labs plus dental, vision, and hearing coverage. Ad
- 2026-10-0107:08 UTCAdditional 2027 highlights include:Medicare Advantage plans in approximately 2,600 counties across 45 states and Washington, D.C., representing more than 80% of U.S. counties.Expanded Chronic Condition Special Needs
- 2026-09-2916:16 UTCWhat a time it’s been for Humana. In the past six months alone, the company’s stock price has increased by a massive 136%, reaching $391.06 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
- 2026-09-2702:08 UTCHumana (HUM) moved sharply higher this week after Barclays shifted its rating on the insurer to Overweight from Equalweight, indicating that the shares could outperform sector peers. At around US$397.93, Humana’s recent 4.63% 1 day share price return and 3.21% 30 day share price return build on a strong year to date share price return of 50.46%. However, the 3 year total shareholder return has dec
- 2026-09-2602:40 UTCShares of health insurance company Humana (NYSE:HUM) jumped 8% in the afternoon session after Barclays upgraded the stock from Equalweight to Overweight.
- 2026-09-2518:59 UTCInvesting.com -- Humana Inc. (NYSE:HUM) shares rose 6% Friday after Barclays upgraded the health insurer to overweight from equal-weight ahead of the upcoming Medicare Star ratings release.
- 2026-09-2517:59 UTCBarclays just broke its silence on Humana with a conviction call that sent shares surging well past anything the broader health care sector is doing today, raising the question of whether this upgrade signals the start of something bigger or a rally built on a single opinion.
- 2026-09-2516:09 UTCBarclays upgraded Humana stock to Overweight from Neutral and raised its price target to $515 from $407.
- 2026-09-2514:47 UTCAnalysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while maintaining Stem’s $7 target.
- 2026-09-2511:38 UTCBarclays analyst Andrew Mok upgrades Humana (NYSE:HUM) from Equal-Weight to Overweight and raises the price target from $407 to $515.
- 2026-09-0317:32 UTC
- 2026-09-0111:30 UTC
- 2026-08-3113:47 UTC
- hidden12 provider-tagged items never name the company and are kept as context only.
canonical items of the last 10 sessions; analyst/industry/macro commentary and social sources excluded from the direction tally; gating uses tier 1-3 HIGH items within 3 (negative) / 2 (unknown direction) sessions
Catalysts and filings
| Event | Date | In | Materiality | Source |
|---|---|---|---|---|
| Earnings (before the open) | 2026-11-06 | 24 sessions | high | finnhub · Tier 3 · provider |
Options activity
- Session volume
- 374
- 5D baseline
- 366
- 20D baseline
- 413
- Volume / 20D
- 0.91x
- Call / put volume
- 179 / 195
- Call / put ratio
- 0.92
- Top-3 contract share
- 77%
- Top expiration
- 2026-10-16 91%
Activity trend · last 30 sessions
| Session | Volume | 5D | 20D | / 20D |
|---|---|---|---|---|
| 2026-09-22 | 73 | 319 | 373 | 0.20x |
| 2026-09-23 | 79 | 290 | 354 | 0.22x |
| 2026-09-24 | 562 | 276 | 355 | 1.58x |
| 2026-09-25 | 770 | 304 | 379 | 2.03x |
| 2026-09-28 | 374 | 366 | 413 | 0.91x |
Call vs put volume
Expiration concentration
Contract concentration
Top contracts · session 2026-09-28
| Contract | Type | Strike | Expiration | DTE | Volume | 5D avg | 20D avg | / 20D | Return | Moneyness |
|---|---|---|---|---|---|---|---|---|---|---|
| O:HUM261016P00400000 | PUT | 400 | 2026-10-16 | 18 | 140 | 45 | 70 | 2.00x | 13.1% | ITM (-2.6%) |
| O:HUM261016C00400000 | CALL | 400 | 2026-10-16 | 18 | 120 | 27 | 51 | 2.36x | -11.1% | OTM (-2.6%) |
| O:HUM261016C00390000 | CALL | 390 | 2026-10-16 | 18 | 28 | 186 | 58 | 0.48x | 0.3% | ATM (-0.1%) |
| O:HUM261016P00390000 | PUT | 390 | 2026-10-16 | 18 | 20 | 7 | 18 | 1.12x | 9.2% | ATM (-0.1%) |
| O:HUM261016C00385000 | CALL | 385 | 2026-10-16 | 18 | 10 | insufficient history | insufficient history | insufficient history | 0.0% | ITM (1.2%) |
| O:HUM261016C00395000 | CALL | 395 | 2026-10-16 | 18 | 10 | insufficient history | insufficient history | insufficient history | 0.0% | OTM (-1.4%) |
| O:HUM261016P00380000 | PUT | 380 | 2026-10-16 | 18 | 10 | 17 | 140 | 0.07x | 20.0% | OTM (2.5%) |
| O:HUM261009P00400000 | PUT | 400 | 2026-10-09 | 11 | 9 | 2 | insufficient history | insufficient history | 8.3% | ITM (-2.6%) |
| O:HUM261009C00390000 | CALL | 390 | 2026-10-09 | 11 | 7 | 3 | insufficient history | insufficient history | 0.6% | ATM (-0.1%) |
| O:HUM261009P00397500 | PUT | 397.5 | 2026-10-09 | 11 | 5 | insufficient history | insufficient history | insufficient history | 4.4% | ITM (-2.0%) |
| O:HUM261009P00392500 | PUT | 392.5 | 2026-10-09 | 11 | 3 | insufficient history | insufficient history | insufficient history | 5.7% | ITM (-0.7%) |
| O:HUM261009P00395000 | PUT | 395 | 2026-10-09 | 11 | 3 | 5 | insufficient history | insufficient history | 6.8% | ITM (-1.4%) |
| O:HUM261009P00385000 | PUT | 385 | 2026-10-09 | 11 | 2 | 5 | insufficient history | insufficient history | 0.0% | OTM (1.2%) |
| O:HUM261009P00387500 | PUT | 387.5 | 2026-10-09 | 11 | 2 | insufficient history | insufficient history | insufficient history | 0.0% | OTM (0.5%) |
| O:HUM261009C00380000 | CALL | 380 | 2026-10-09 | 11 | 1 | 4 | insufficient history | insufficient history | 0.0% | ITM (2.5%) |
OPTIONS_SELECTION_M9_V1 selected contracts only · provider capability DELAYED · delayed · Top 15 selected contracts by session volume; 5D/20D averages use strictly prior sessions (M10), INSUFFICIENT_HISTORY is shown, never zero.
M13 observations for this session
- Technical setup present (PRE_BREAKOUT_V1): FALSE
- Technical and options context share a session: FALSE
- Activity above its own 20-session baseline: FALSE
- Activity below its own 20-session baseline: FALSE
- Recent 5-session baseline above 20-session baseline: FALSE
- Recent 5-session baseline below 20-session baseline: FALSE
- Volume concentrated in top 3 contracts: TRUE
- Volume concentrated in one expiration: TRUE
- Calls carry most session volume: FALSE
- Puts carry most session volume: FALSE
- Call and put volume roughly balanced: TRUE
- Enrichment data (snapshot/OI/IV/Greeks) available: FALSE
- Enrichment data unavailable: TRUE
- Real flow data unavailable: TRUE
- Flow events present in replay window: NOT_EVALUABLE
Flow
Flow engine is ready. Trades and Quotes are not available with the current provider capabilities; this area populates automatically from the same M11 engine when real persisted facts exist. Synthetic fixture flow is never shown.
Evidence alerts
| Category | Alert | Previous | Current | Sessions | Workflow | Actions |
|---|---|---|---|---|---|---|
| Changed | Distance to resistance narrowed | 3.35 | 1.15 | 2026-10-01 → 2026-10-02 | New | |
| Fading | Options activity vs 20D baseline fell | 2.03 | 0.91 | 2026-09-25 → 2026-09-28 | New | |
| Changed | Call / put volume mix changed | 0.62 | 0.48 | 2026-09-25 → 2026-09-28 | New | |
| Data quality | Data freshness changed | TECHNICAL=CURRENT_SESSION; OPTIONS_ACTIVITY=STALE; FLOW=MISSING; ACTIVITY_PROVIDER=DELAYED | TECHNICAL=CURRENT_SESSION; OPTIONS_ACTIVITY=DELAYED; FLOW=MISSING; ACTIVITY_PROVIDER=DELAYED | 2026-10-01 → 2026-10-02 | New |
Decision trace
- setup_eligibleFAILNO_SETUP: failed relative_strength_20failed_conditions=relative_strength_20
- finalPASSAVOID
Actions are generated from the configured trading strategy and current available market/intelligence data. They are not guarantees of future performance.